| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2460640C Diaryl ether derivatives, salts thereof and immunosuppressive agents using the same |
| 03/29/2011 | CA2448083C Liquid preparations of fudosteine |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | WO2011034896A2 Small molecule inhibitors of the alpha4-paxillin interaction |
| 03/24/2011 | WO2011034580A2 Small peptide modulators of potassium channel trafficking |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011033470A1 Crystalline form of montelukast sodium |
| 03/24/2011 | WO2011033055A1 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | WO2011032233A1 Novel omega conotoxin peptides |
| 03/24/2011 | WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071206 Modulators of ATP-Binding Cassette Transporters |
| 03/24/2011 | US20110071204 Percutaneous absorption preparation |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071194 Chemical Compounds 572 |
| 03/24/2011 | US20110071190 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/24/2011 | US20110071185 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071175 Indoles and Their Therapeutic Use |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071150 Indole derivatives as crac modulators |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 03/24/2011 | US20110070309 Pharmaceutical formulation comprising a water-insoluble active agent |
| 03/24/2011 | US20110070290 Vaccine composition containing synthetic adjuvant |
| 03/24/2011 | US20110070247 Protein modulators |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070236 Use of immunesuppressant receptor |
| 03/24/2011 | US20110070216 Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 03/24/2011 | US20110070167 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/24/2011 | CA2772105A1 Fused triazole amines as p2x7 modulators |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298415A1 Micronisation method |
| 03/23/2011 | EP2298359A1 Nucleic acid capable of controlling degranulation of mast cell |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298348A1 Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease |
| 03/23/2011 | EP2298308A2 Integrin-binding small molecules |
| 03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) |
| 03/23/2011 | EP2298298A2 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
| 03/23/2011 | EP2298285A2 Method of making particles for use in a pharmaceutical composition |
| 03/23/2011 | EP2298279A2 Pharmaceutical compositions for inhalation |
| 03/23/2011 | EP2296684A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 03/23/2011 | EP2019837B1 Compounds and compositions as channel activating protease inhibitors |
| 03/23/2011 | EP1650218B1 The artificial cpg single strand deoxidation oligonucleotide and its antiviral uses |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1448205B1 Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2011 | EP1353647B1 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN1943734B A Chinese traditional medicine for clearing away heat and toxic material |
| 03/23/2011 | CN1929824B Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid |
| 03/23/2011 | CN1895365B Oral liquid for treating fowl upper disease and its preparation |
| 03/23/2011 | CN101987844A Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride |
| 03/23/2011 | CN101987190A Traditional Chinese medicine for efficiently treating rhinitis |
| 03/23/2011 | CN101987171A Traditional Chinese medicine for treating tracheitis and benefiting throat |
| 03/23/2011 | CN101987165A Aerosol for treating faucitis and preparation method thereof |
| 03/23/2011 | CN101987146A Preparation method of capsule for treating pharyngitis and infection of upper respiratory tract and detection method of capsule |
| 03/23/2011 | CN101987142A Active ingredient detection method of traditional Chinese medicine soft capsule |
| 03/23/2011 | CN101664449B Separation method of rhubarb-combined anthraquinone and rhubarb tannin |
| 03/23/2011 | CN101485827B Medicament for treating chronic inflammation disease of throat |
| 03/23/2011 | CN101485823B Medicament for treating lung cancer and preparation method thereof |
| 03/23/2011 | CN101474191B Pharmaceutical composition for treating asthma and chronic obstructive pulmonary disease |
| 03/23/2011 | CN101468089B Chinese medicinal composition for diffusing lung, relieving exterior syndrome, suppressing cough and reducing phlegm and preparation method thereof |
| 03/23/2011 | CN101433669B Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 03/23/2011 | CN101322733B Chinese herbal medicine formulation for treating pollution lung disease |
| 03/23/2011 | CN101204462B Chinese traditional medicine preparation for liver and kidney eficiencyofyin epistaxis |
| 03/23/2011 | CN101199753B Oral administration Chinese medicine for treating dryness-heat cough hemoptysis |
| 03/23/2011 | CN101199674B Chinese medicine preparation for treating pathogenic heat excessive type epistaxis |
| 03/22/2011 | US7910741 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders |
| 03/22/2011 | US7910593 Water-soluble prodrugs |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2487238C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2464735C An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/22/2011 | CA2406201C Improvements in or relating to formulations for use in inhaler devices |
| 03/17/2011 | WO2011031713A2 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
| 03/17/2011 | WO2011030873A1 Benzyl compounds |
| 03/17/2011 | WO2011030872A1 Sulfonamide compounds |
| 03/17/2011 | WO2011030871A1 N-substituted heteroaryl compounds |
| 03/17/2011 | WO2011030868A1 Substituted carbonyl compounds |
| 03/17/2011 | WO2011030865A1 Substituted zenzyl compounds |